Investment




Hetero announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India to treat mild to moderate Covid-19.

HYDERABAD, INDIA, 29th JULY, 2020 (GPN): Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, today announces the launch of generic Favipiravir in India under the brand name…


What COVID-19 means for the data breach landscape?

DELHI, 28 JULY, 2020 (GPN): A three-month analysis on the possible impact of COVID-19 on the data breach landscape has shed light on an increasing number of threat actors worrying cyber-security specialists. The Verizon Business…